Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» XYOSTED
XYOSTED
Bucking the trend, Antares gains FDA OK for testosterone rejection on second try
Bucking the trend, Antares gains FDA OK for testosterone rejection on second try
Endpoints
Antares Pharma
XYOSTED
testosterone
FDA
Flag link:
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
Flag link: